1. CRISPR tech raises urgent ethical questions, say original DNA pioneers

CRISPR-Cas9 is raising many questions, and scientists say it should not be used to change human DNA until all risks have been thoroughly researched and ethical issues taken into consideration.

2. De-identifying Clinical Trials Data

De-identifying trial participants personal information must be done, and this article describes the strengths and weaknesses of methods that can be used to do that.

3.  Why clinical trial recruitment is so hard, and one solution: Patient education  Clinical trial participants are difficult to find because of the public’s lack of knowledge and this article claims, “It serves as a much-needed call-to-action for the many would-be clinical trial participants.”